S100A8 -a new target to prevent T cell exhaustion BsAbs in myeloma | Adolfo Aleman, PhD |
Автор: HealthTree University for Multiple Myeloma
Загружено: 2025-12-17
Просмотров: 185
Описание:
T-cell exhaustion remains a major challenge in bispecific antibody (BsAb) therapy for multiple myeloma, limiting durability of response and long-term disease control. In this #ASH25 presentation, Adolfo Aleman, PhD, explores S100A8 as a novel immunologic target to prevent or reverse T-cell exhaustion in the setting of BsAb treatment.
If this video has helped you or a loved one, consider donating to HealthTree. Every donation helps us continue to create free and high-quality blood cancer educational content: https://give.healthtree.org/give/6286...
For an organized lesson structure, watch on our site here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!
Patients have the key to find cures for cancer. Learn more about HealthTree's services here: https://healthtree.org/curehub?utm_so...
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
